2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Berkson Avram | — | 4,307,003 | Nov 30, 2016 |
| Berkson Sandra | — | 4,307,003 | Nov 30, 2016 |
| Lewkowicz Leon | 10% Owner | 3,078,214 | Jun 20, 2017 |
| Alpha Capital Anstalt | — | 1,776,457 | Nov 30, 2016 |
| Shoham Moshe | Director | 1,558,390 | Oct 10, 2017 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Feb 20, 2026 | Gadot Harel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2026 | Feb 20, 2026 | Diaz-Cartelle Juan | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2026 | Feb 20, 2026 | Sharon Simon | General Manager, CTO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2026 | Feb 20, 2026 | Vaknin Rachel | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 5, 2025 | Feb 7, 2025 | Vaknin Rachel | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 5, 2025 | Feb 7, 2025 | Gadot Harel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 5, 2025 | Feb 7, 2025 | Sharon Simon | General Manager, CTO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 5, 2025 | Feb 7, 2025 | Diaz-Cartelle Juan | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 28, 2025 | Jan 30, 2025 | Madden Martin J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 28, 2025 | Jan 30, 2025 | Burell Scott R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 28, 2025 | Jan 30, 2025 | Wenderow Tal Baruch | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 28, 2025 | Jan 30, 2025 | Wilson David James | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 28, 2025 | Jan 30, 2025 | Stockburger Aileen Ptucha | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 28, 2025 | Jan 30, 2025 | Laxminarain Prattipati | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 16, 2025 | Wilson David James | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 22, 2024 | Feb 26, 2024 | Diaz-Cartelle Juan | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 22, 2024 | Feb 26, 2024 | Sharon Simon | General Manager, CTO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 22, 2024 | Feb 26, 2024 | Vaknin Rachel | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 22, 2024 | Feb 26, 2024 | Gadot Harel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 1, 2023 | Diaz-Cartelle Juan | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 2, 2023 | Nov 6, 2023 | Burell Scott R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 2, 2023 | Nov 6, 2023 | Wenderow Tal Baruch | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 2, 2023 | Nov 6, 2023 | Bornstein Yoseph | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 2, 2023 | Nov 6, 2023 | Stockburger Aileen Ptucha | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 2, 2023 | Nov 6, 2023 | Madden Martin J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 2, 2023 | Nov 6, 2023 | Laxminarain Prattipati | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 1, 2023 | Aug 3, 2023 | Gadot Harel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 1, 2023 | Aug 3, 2023 | Sharon Simon | General Manager, CTO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 1, 2023 | Aug 3, 2023 | Morag Eyal | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 1, 2023 | Aug 3, 2023 | Vaknin Rachel | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 17, 2023 | Jan 19, 2023 | Morag Eyal | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 17, 2023 | Jan 19, 2023 | Sharon Simon | General Manager, CTO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 21, 2022 | Jan 9, 2023 | Vaknin Rachel | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 21, 2022 | Jan 9, 2023 | Gadot Harel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 21, 2022 | Sep 23, 2022 | Stockburger Aileen Ptucha | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 21, 2022 | Sep 23, 2022 | Bornstein Yoseph | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 21, 2022 | Sep 23, 2022 | Madden Martin J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 21, 2022 | Sep 23, 2022 | Wenderow Tal Baruch | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 21, 2022 | Sep 23, 2022 | Burell Scott R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 21, 2022 | Sep 23, 2022 | Laxminarain Prattipati | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 18, 2022 | Jul 20, 2022 | Vaknin Rachel | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 15, 2022 | Vaknin Rachel | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 26, 2022 | Jan 28, 2022 | Morag Eyal | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 26, 2022 | Jan 28, 2022 | Sharon Simon | General Manager, CTO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 26, 2022 | Jan 28, 2022 | Gadot Harel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 29, 2021 | Oct 5, 2021 | Wenderow Tal Baruch | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 29, 2021 | Oct 5, 2021 | Stockburger Aileen Ptucha | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 29, 2021 | Oct 5, 2021 | Laxminarain Prattipati | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 29, 2021 | Oct 5, 2021 | Burell Scott R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 29, 2021 | Oct 5, 2021 | Bornstein Yoseph | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 29, 2021 | Oct 5, 2021 | Madden Martin J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 7, 2021 | Sharon Simon | General Manager & CTO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 1, 2021 | Feb 3, 2021 | Gadot Harel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 5, 2020 | Nov 9, 2020 | Laxminarain Prattipati | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 5, 2020 | Nov 9, 2020 | Burell Scott R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 5, 2020 | Nov 9, 2020 | Bornstein Yoseph | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 5, 2020 | Nov 9, 2020 | Madden Martin J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 12, 2020 | Oct 21, 2020 | Bornstein Yoseph | Director | Sell | 32.5 | -20,000 | -7.49% | ✓ | $156.9K |
| Oct 19, 2020 | Oct 21, 2020 | Bornstein Yoseph | Director | Sell | 48.8 | -4,881 | -1.98% | ✓ | $38.7K |
| Oct 5, 2020 | Oct 13, 2020 | Bornstein Yoseph | Director | Sell | 32.5 | -20,000 | -7.49% | ✓ | $156.9K |
| Oct 5, 2020 | Oct 6, 2020 | Bornstein Yoseph | Director | Sell | 32.5 | -20,000 | -6.97% | ✓ | $154.9K |
| Aug 14, 2020 | Sep 9, 2020 | Wenderow Tal Baruch | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 9, 2020 | Wenderow Tal Baruch | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 17, 2020 | Aug 19, 2020 | Bornstein Yoseph | Director | Sell | 32.5 | -15,119 | -5.01% | ✓ | $154.1K |
| Jul 14, 2020 | Jul 16, 2020 | Morag Eyal | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 14, 2020 | Jul 16, 2020 | Stockburger Aileen Ptucha | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 7, 2020 | Morag Eyal | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 1, 2020 | Stockburger Aileen Ptucha | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 25, 2020 | Feb 27, 2020 | Gadot Harel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 23, 2019 | Dec 26, 2019 | Gadot Harel | CEO | Sell | 12.5 | -40,000 | -22.62% | ✓ | $400K |
| Jan 8, 2019 | Oct 28, 2019 | Mona Joseph | 10% Owner | Sell | 17.5 | -285,322 | -100.00% | ✗ | $2.3M |
| Oct 23, 2019 | Oct 24, 2019 | Bornstein Yoseph | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 23, 2019 | Oct 24, 2019 | Madden Martin J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 23, 2019 | Oct 24, 2019 | Burell Scott R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 23, 2019 | Oct 24, 2019 | Laxminarain Prattipati | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 23, 2019 | Oct 24, 2019 | Waizer Yoav Zvi | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 18, 2019 | Mona Joseph | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 8, 2019 | Oct 18, 2019 | Mona Joseph | 10% Owner | Buy | 42.5 | - | 0.00% | ✗ | $2.3M |
| Nov 19, 2018 | Oct 18, 2019 | Mona Joseph | 10% Owner | Buy | 90.0 | +71,568 | 5.40% | ✗ | $154.9K |
| Jan 21, 2019 | Jan 23, 2019 | Laxminarain Prattipati | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 21, 2019 | Jan 23, 2019 | Burell Scott R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 21, 2019 | Jan 23, 2019 | Bornstein Yoseph | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 21, 2019 | Jan 23, 2019 | Waizer Yoav Zvi | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 21, 2019 | Jan 23, 2019 | Madden Martin J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 28, 2017 | Jan 24, 2018 | Naim David Ben | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 9, 2018 | Jan 10, 2018 | Bornstein Yoseph | Director | Sell | 51.3 | -35,000 | -0.77% | ✓ | $37.2K |
| Jan 3, 2018 | Jan 4, 2018 | Bornstein Yoseph | Director | Sell | 56.3 | -2,868 | -0.06% | ✓ | $2.9K |
| Jan 2, 2018 | Jan 3, 2018 | Bornstein Yoseph | Director | Sell | 51.3 | -42,132 | -0.91% | ✓ | $42.5K |
| Dec 27, 2017 | Dec 28, 2017 | Bornstein Yoseph | Director | Sell | 52.5 | -14,257 | -0.31% | ✓ | $14.6K |
| Dec 26, 2017 | Dec 27, 2017 | Bornstein Yoseph | Director | Sell | 51.3 | -30,743 | -0.66% | ✓ | $31.4K |
| Dec 19, 2017 | Dec 21, 2017 | Bornstein Yoseph | Director | Sell | 52.5 | -45,000 | -0.48% | ✓ | $46.4K |
| Dec 14, 2017 | Laxminarain Prattipati | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 13, 2017 | Dec 14, 2017 | Bornstein Yoseph | Director | Sell | 58.8 | -841 | -0.02% | ✓ | $857.8 |
| Dec 12, 2017 | Dec 13, 2017 | Bornstein Yoseph | Director | Sell | 51.3 | -44,159 | -0.93% | ✓ | $45.8K |
| Dec 6, 2017 | Dec 8, 2017 | Waizer Yoav Zvi | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 6, 2017 | Dec 8, 2017 | Madden Martin J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 6, 2017 | Dec 8, 2017 | Burell Scott R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 6, 2017 | Dec 8, 2017 | Bornstein Yoseph | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 6, 2017 | Dec 7, 2017 | Bornstein Yoseph | Director | Sell | 52.5 | -15,375 | -0.32% | ✓ | $16.2K |
| Dec 5, 2017 | Dec 6, 2017 | Bornstein Yoseph | Director | Sell | 51.3 | -29,625 | -0.62% | ✓ | $32.1K |